The QualityStocks Daily Wednesday, August 21st, 2019

Today's Top 3 Investment Newsletters

QualityStocks (STLT) +135.54%

BUYINS.NET (WTRH) +34.06%

StockMarketWatch (LEDS) +30.41%

The QualityStocks Daily Stock List

Kraig Biocraft Laboratories, Inc. (KBLB)

StockPulse, Investor Village, TipRanks, Infront Analytics, Discovery Stocks, Emerging Growth, Stockhouse, Wallet Investor, Super Stock Screener, InvestorsHub, Insider Financial, Trading View, and Simply Wall St reported earlier on Kraig Biocraft Laboratories, Inc. (KBLB), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Kraig Biocraft Laboratories, Inc. is the leading developer of genetically engineered spider silk based fibers. The OTCQB-listed Company has realized a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry. Its genetic engineering research has succeeded in developing what many consider to be the holy grail of material science – a practical and cost-effective technology for producing recombinant spider silk based fibers on an industrial scale. Kraig Biocraft Laboratories has its head office in Ann Arbor, Michigan.

Kraig Biocraft Laboratories obtained at its inception, proprietary genetic engineering technology to unlock the mystery of producing spider silk. In early 2006, It obtained certain exclusive rights from the University of Wyoming to use the spider silk gene sequences in its field of use. At present, the Company is ramping up production of its Monster Silk™ and Dragon Silk™ for commercialization. In addition, it is continuing to develop new and recombinant spider silk fibers.

Spider Silk is among the strongest fibers produced in nature. Some spider species can produce up to seven different kinds of silk depending upon the spider’s particular need at that time. Spider silk holds the potential of a lifesaving ballistic resistant material - lighter, thinner, flexible and hardier than steel material.

Polartec and Kraig Biocraft Laboratories announced in April 2019 plans to bring to market the first fabrics made from spider silk. Initially developed for specialized military applications, these first-of-their-kind materials made from recombinant spider silk will ultimately service the worldwide market for high performance textiles and apparel. Polartec is the premium provider of unique and sustainable textile solutions.

Kraig Biocraft Laboratories recently announced that it has created the next generation of recombinant spider silk using the Company’s new design, gene editing, and incorporation approaches. Kraig Labs designed this approach to customize mechanical properties for specific commercial markets. It has demonstrated the ability to more rapidly, accurately, and efficiently, generate new transgenics.

Earlier this month, Kraig Biocraft Laboratories announced that it completed construction of its new biotech research laboratory in Vietnam. The new laboratory suite is located within the Company’s recombinant spider silk production facility in Quang Nam, Vietnam. It consists of eleven separate labs. The new labs are a vital piece of Kraig Biocraft’s spider silk commercialization program. They were part of the, now complete, renovation efforts at the Prodigy Textiles factory, Kraig Biocraft’s wholly-owned subsidiary and production arm.

Today, Kraig Biocraft Laboratories announced it has expanded its team with the addition of its first biological engineer to the research and development (R&D) department. This new hire brings broad experience working with spider silks. Working directly with Kraig’s Chief Scientist, she is already developing new and stronger transgenics and providing valuable input shaping the direction Kraig Biocraft’s research is headed.

Kraig Biocraft Laboratories, Inc. (KBLB), closed Wednesday's trading session at $0.22742, off by 5.1231%, on 1,565,765 volume with 131 trades. The average volume for the last 3 months is 4,154,369 and the stock's 52-week low/high is $0.035199999/$0.507000029.

chart

Western Uranium & Vanadium Corp. (WSTRF)

Zacks, Dividend Investor, Energy and Capital, Streetwise Reports, Trading View, Junior Mining Network, GlobeNewswire, Vanadium Price, Stockhouse, Proactive Investors, Investor Intel, Stockwatch, Morningstar, and Market Screener reported beforehand on Western Uranium & Vanadium Corp. (WSTRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Western Uranium & Vanadium Corp. is a uranium and vanadium conventional mining company. It concentrates on low cost near-term production of uranium and vanadium in the western U.S., as well as the development and application of ablation mining technology. Ablation Mining Technology (AMT) is a proprietary process that improves efficiency and decreases costs for sandstone hosted deposits. Western Uranium & Vanadium has offices in Toronto, Ontario and Nucla, Colorado. The Company lists on the OTC Markets Group’s OTCQX.

Western Uranium & Vanadium is among the largest U.S. Uranium and Vanadium in-situ resource holders. The Company has a total uranium resource of 70,000,000 lbs. +/- and a total vanadium resource of 35,000,000 lbs. +/- grading between 1.4-2.2 percent. Its near-term production strategy includes focusing on previously producing mines for low capex (capital expenditures), existing infrastructure, and permitting.

The Company’s strategy additionally includes defining and developing a high-grade vanadium resource at the Sunday Mine Complex (SMC). Its strategy is also to deliver SMC ore samples to numerous potential customers and joint venture (JV) partners, and baseload SMC production with a vanadium ore concentrate agreement.

Furthermore, Western Uranium & Vanadium’s strategy is to pursue vanadium development at the Sage Mine Project. It will also work to pursue uranium contracts and development at prices above present price levels.

In July, Western Uranium & Vanadium updated the status of the Sunday Mine Complex Vanadium Project. Four of the five Mines at the Sunday Mine Complex have been opened to mainly evaluate the vanadium resources that were not mined in the past.

After the mining team completed the ventilation requirements and determined the mines were safe to fully enter, Dr. Kaiwen Wu, Western Uranium & Vanadium’s Chief Geologist, located four initial areas where the vanadium readings on the X-Ray Fluorescence analyzer (XRF) were high. Sampling from the face of the mine workings showed V2O5 grades ranging from 3 percent to 14 percent. The high-grade vanadium zones will now be considerably sampled to ascertain expected production grades.

Western Uranium & Vanadium Corp. (WSTRF), closed Wednesday's trading session at $0.72, up 7.2067%, on 6,110 volume with 5 trades. The average volume for the last 3 months is 31,947 and the stock's 52-week low/high is $0.605099976/$2.69889998.

chart

Golden Matrix Group, Inc. (GMGI)

TipRanks, Stock Muse, TraderNewsWire, OTC Markets, Real Investment Advice, Simply Wall St, Wallet Investor, Infront Analytics, Market Screener, 4-Traders, Nasdaq, Stockhouse, TradingView, Last10k, Dividend Investor, Stockopedia, GlobeNewswire, and InvestorsHub reported beforehand on Golden Matrix Group, Inc. (GMGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A technology-driven enterprise, Golden Matrix Group, Inc. designs and develops social gaming platforms, systems and gaming content. It develops and owns online gaming IP (Intellectual Property) and builds configurable and scalable white-label social gaming platforms for its global customers, located mainly in the Asia Pacific region. The Company was previously known as Source Gold Corp. It changed its name to Golden Matrix Group, Inc. in March of 2016. Established in 2008, Golden Matrix Group has its corporate office in Las Vegas, Nevada.

Golden Matrix pioneers highly modular, configurable, and scalable social gaming platforms for its customers. This is to promote user acquisition, engagement, retention, as well as monetization.

The Company’s platform enhances clients’ ability to cater to different gaming scenarios. This includes, but is not limited to, transaction management and a range of loyalty/reward programs. In addition, user engagement is optimized via Golden Matrix’s ability to accommodate free and cost to play games.

Regarding its Services, Golden Matrix has a completely operational platform. This platform delivers all features and services required to introduce a white label social gaming site. The Company offers Management services. It has a single suite of integrated applications to collect, store, manage and interpret real-time gaming data.

Services include incentivising users with credits, prizes and rewards. Therefore, this enhances user engagement and retention. Moreover, Golden Matrix provides access to first-rate games across in-demand gaming genres. It also provides updates – the continual updating of gaming features and the addition of new games to lessen content sourcing. Golden Matrix’s sophisticated software automatically declines any gaming or redemption requests from within the U.S., in strict compliance with present U.S. law.

Today, Golden Matrix said that Red Label Technology 'REDLABEL', one of its major distributors servicing the Asia Pacific (APAC) region, generated multi-million dollars in Golden Matrix gameplay during the company’s fourth fiscal (July 31) quarter. This resulted in revenue due to Golden Matrix Group of $285,247, up 73 percent from $164,772 received from REDLABEL in the company’s third fiscal (April 30) quarter.

Golden Matrix derives its revenues mainly from licensing fees received from gaming operators located in the Asia Pacific (APAC) region and integrated with its state-of-the-art GM-X platform. At present, there are more than 300 active operators and greater than 1.5 million registered users across all gaming operator/GM-X platforms.

Golden Matrix Group, Inc. (GMGI), closed Wednesday's trading session at $0.006524, up 38.8085%, on 32,630,706 volume with 290 trades. The average volume for the last 3 months is 7,039,693 and the stock's 52-week low/high is $0.0006/$0.006699999.

chart

Adynxx, Inc. (ADYX)

TipRanks, TMXmoney, Xconomy, Street Insider, Investing.com, BioCentury, Stockhouse, Market Screener, TradingView, Stockopedia, Dividend Investor, GlobeNewswire, and PR Newswire reported previously on Adynxx, Inc. (ADYX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A clinical stage biopharmaceutical company, Adynxx, Inc. focuses on bringing to market novel, disease-modifying products for the treatment of pain and inflammation. The Company’s pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including inflammatory and neuropathic pain. Fundamentally, Adynxx is a leader in transcription factor decoy technology. Established in 2007, Adynxx has its corporate headquarters in San Francisco, California.

The Company has worked since its founding to discover and develop transcription factor decoys to modify the course of pain, to collaborate with discovery partners, and to identify in-licensing opportunities with transformative therapeutic profiles to build a pipeline in pain and inflammation.

Adynxx is collaborating with twoXAR to use twoXAR’s artificial intelligence-driven drug discovery platform. This is to identify endometriosis treatments. In addition, Adynxx is evaluating in-licensing opportunities with transformative therapeutic profiles to treat pain and inflammation.

The AYX platform employs a proprietary technology of non-opioid, disease-modifying transcription factor decoys. AYX decoys are short DNA molecules, or oligonucleotides. They selectively inhibit transcription factors controlling the genes involved in the maintenance of pain. Therefore, a single administration of an AYX decoy generates a strong, long-term reduction of pain and associated clinical benefits.

Clinical studies suggest that a single administration of brivoligide at the time of surgery can safely lessen pain for weeks, speed up the time to attain mild pain and considerably decrease the need for opioid use during recovery specifically in patients at greater risk of experiencing increased and prolonged pain following surgery.

Recently, Adynxx announced that Mr. Gregory J. Flesher, Chief Executive Officer (CEO) at Novus Therapeutics, Inc. (NASDAQ: NVUS), was appointed to the Adynxx Board of Directors. Since May of 2017, Mr. Flesher has served as the CEO and a member of the Board of Directors of Novus Therapeutics, a specialty pharmaceutical company centered on developing products for patients with disorders of the ear, nose and throat.

For Q2 of 2019, Adynxx reported a Net Loss of $4.7 million, versus a Net Loss of $1.4 million for the same period in 2018. Research and development expenses were $1.9 million in Q2 of 2019, versus $0.6 million for the same period in 2018. This increase was mainly because of $0.7 million in connection with start-up activities related to Adynxx's planned Phase 2 ADYX-005 total knee arthroplasty and Phase 2 ADYX-006 mastectomy clinical trials and $0.7 million related to the initiation of drug supply manufacturing with Avecia, partially offset by a decrease in salaries and benefits from the resignation of an employee and other minor cost changes.

Adynxx, Inc. (ADYX), closed Wednesday's trading session at $2.07, off by 2.3585%, on 3,365 volume with 19 trades. The average volume for the last 3 months is 2,011 and the stock's 52-week low/high is $1.91999995/$31.4400005.

chart

ARC Group, Inc. (RLLY)

Zacks, MacroTrends, Infront Analytics, Market Screener, Simply Wall St, InvestorsHub, TMXmoney, Stockhouse, Stockwatch, GlobeNewswire, and Dividend Investor reported earlier on ARC Group, Inc. (RLLY), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

ARC Group, Inc. is a restaurant holding company with an emphasis on diversified, full-service restaurants and brands. It is the owner, operator and franchisor of Dick’s Wings & Grill®, a family-oriented restaurant chain with locations in Florida and Georgia. The Company previously went by the name American Restaurant Concepts, Inc. It changed its name to ARC Group, Inc. in June of 2014. OTCQB-listed and established in April 2000, ARC Group is headquartered in Orange Park, Florida.

ARC Group operates four company-owned restaurants and a number of concession stands at TIAA Bank Field. The Company has 16 franchise locations. In addition, ARC owns the Fat Patty’s® concept, with four locations in West Virginia and Kentucky. ARC Group’s differentiators are its sauces, seasonings and micro brews.

Dick’s Wings serves more than 25,000 wings daily. It features its award-winning chicken wings, hog wings and duck wings spun in its signature sauces and seasonings. The Dick’s Wings concept consists of traditional restaurants like the Company’s Dick’s Wings & Grill® restaurants, which are full service restaurants, and non-traditional units like its Dick’s Wings concession stands at EverBank Field. Dick’s Wings offers an assortment of boldly-flavored menu items. These are highlighted by its Buffalo, New York-style chicken wings spun in the Company’s signature sauces and seasonings.

Fat Patty’s offers several specialty burgers and sandwiches, wings, appetizers, salads, wraps, and steak and chicken dinners. It offers these in a family friendly, casual dining environment. Fat Patty’s offers lunch and dinner menus, including a full-service bar, with dine-in and take-out services.

In July, ARC Group announced the appointment of Mr. Alex Andre as Chief Financial Officer. Moreover, Mr. Andre will be appointed as General Counsel once licensing and registration requirements are completed in Florida. Mr. Andre brings almost two decades of executive management, financial, legal and operational experience. Before joining ARC Group, he served as the Co-Founder and Co-Manager of THS Ventures, LLC.

Last week, ARC Group provided a business update for Q2 ended June 30, 2019. Revenue increased 276 percent to $4,188,967 during Q2 2019 from $1,114,587 during Q2 2018. Loss from Operations was $308,016 for Q2 2019 versus $130,880 during Q2 2018.

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) was $191,134 for Q2 2019 versus $(36,404) for Q2 2018. Net Loss was $291,561 for Q2 2019 versus a Net Loss of $55,531 during Q2 2018. Cash flows from Operating Activities increased 79 percent to $328,627 during the six months ended June 30, 2019, from $183,304 during the six months ended June 30, 2018.

ARC Group, Inc. (RLLY), closed Wednesday's trading session at $1.25, even for the day, on 1,000 volume with 00 trades. The average volume for the last 3 months is 000,000 and the stock's 52-week low/high is $1.10000002/$2.0999999.

chart

GrowLife, Inc. (PHOT)

Zacks, CannabisMarketCap, Green Rush Review, Stockopedia, Best Medical Marijuana Stocks, Stockwatch, Wall Street Alerts, Simply Wall St, Market Screener, Energy and Capital, InvestorsHub, TradingView, TMXmoney, Investing.com, Stockhouse and GlobeNewswire reported earlier on GrowLife, Inc. (PHOT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

GrowLife, Inc. is one of the nation’s most recognized indoor cultivation product and service providers. The Company provides farming soil, hydroponics equipment, organic plant nutrients, and other products to specialty grow operations in the U.S. Its goal is to become the nation’s largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. GrowLife is headquartered in Kirkland, Washington.

GrowLife has a complete selection of cultivation products combined with logistics and distribution services. The Company’s focus is on helping responsible cultivation operations efficiently control supply costs, manage build-out investments, track supply usage, and streamline workflows. GrowLife provides essential goods and services via a network of local representatives covering the U.S. and Canada, regional centers, as well as its e-Commerce team.

GrowLife’s retail locations are in Encino, California; Portland, Maine; and Calgary, Alberta. The Company also has its GrowLife Commercial operations.

In July, GrowLife announced that it launched a new platform for its recently majority acquired EZ-CLONE Enterprises, Inc. (EZ-CLONE) cloning and propagation company to serve as the commercial hemp cloning industry’s resource for innovation. The new platform, ezclonehemp.com, is now set to be a trusted resource for cultivators to look for products and education on plant cloning and propagation, purposely designed for hemp growers. The Company received the patent for the design of its EZ-CLONE Pro Commercial Cloning System, “Aeroponics System with Rack and Tray”.

GrowLife Chief Executive Officer, Marco Hegyi, said, “As experts in plant cultivation, we understand that hemp growers are seeking additional information and products that enable them to grow consistent, high-volume hemp plants, and cloning is one of the best ways to achieve this. Through this new platform we clearly define the benefits of cloning, visitors can learn more about our products, make purchases and learn how to grow hemp from clones.”

Last week, GrowLife reported more than $4.4m in Revenue in the first six months of 2019 versus $4.6m in Revenue for all of 2018. The Company reported Gross Profit for the six-month period ending on June 30, 2019 of $1.4 million, versus $187,900 in the same period last year. This represents a 669 percent increase.

GrowLife, Inc. (PHOT), closed Wednesday's trading session at $0.0053, off by 5.3571%, on 8,639,834 volume with 146 trades. The average volume for the last 3 months is 6,624,486 and the stock's 52-week low/high is $0.004993999/$0.0226.

chart

Trucept, Inc. (TREP)

Infront Analytics, Business Insider, Investing Online, Stock News Now, StockPulse, PR Newswire, and Biz Journals reported previously on Trucept, Inc. (TREP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Trucept, Inc. is a top consulting and service provider to the Professional Employer Organization and Consumer Goods industries. Via its subsidiaries, it provides professional employer organization staffing and business processing services to small and medium-size businesses in the U.S. The Company formerly went by the name Smart-Tek Solutions, Inc. It changed its corporate name to Trucept, Inc. in January of 2013. Trucept has its head office San Diego, California. The Company’s shares trade on the OTC Markets.

Trucept services allow customers to outsource human resources tasks. This includes payroll processing, workers' compensation insurance, health insurance, employee benefits, 401k investment services, personal financial management, and income tax consultation primarily related to staffing comprising staff leasing, temporary staffing, and co-employment.

Additionally, Trucept provides healthcare staffing services. The Company’s services also relieve existing and potential customers of the burdens associated with personnel management and control.

This past May, Trucept announced the expansion of its Strategic Marketing and Technology products and services by appointing Fawad Nisar as Executive Vice President for its new wholly-owned subsidiary, Trucept Marketing, Inc. Trucept will assist marketing partners with a CBD (cannabidiol) line to wholesalers and distributors, with a processing and production capacity of 52kg of pure CBD oil per week. Nisar brings valuable expertise within the Cannabis industry, particularly in product development, sales & marketing of CBD.

This week, Trucept announced that it has published its second quarter results for 2019. The Company reported a Gross Profit of $1.1 million. This represents an increase of approximately 30 percent. Trucept earned a Net Profit of roughly $177,00 for the period ending June 30, 2019. This represents an increase of 41 percent from the prior quarter.

Mr. Norman Tipton, Chief Executive Officer of Trucept, said, "Trucept continues to negotiate disputed liabilities and has successfully reduced them by approximately $2.6 million, for a net income increase of about 37 percent from the previous quarter."

Trucept, Inc. (TREP), closed Wednesday's trading session at $0.0299, up 6.7857%, on 16,000 volume with 4 trades. The average volume for the last 3 months is 36,617 and the stock's 52-week low/high is $0.0062/$0.195999994.

chart

Empire Diversified Energy, Inc. (MPIR)

PennyStockHub, Equity Net, Otc Dynamics, Hot Penny Stocks, MarketWatch, Penny Stock Tweets, Dividend Investor, Biz Journals, OTC Markets, InvestorsHub, Morningstar, Investing, Stockhouse, Stockopedia, YCharts, and Investors Hangout reported beforehand on Empire Diversified Energy, Inc. (MPIR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Empire Diversified Energy, Inc.’s primary goal is to serve the challenges of the energy Industry with inventive solutions mainly related to the safe removal and disposal of Coal Combustion Residue (CCR), typically referred to as coal ash, from the nation’s utilities storage ponds. Fundamentally, the Company’s mission is to help clean up the existing environment and develop clean fuel sources in the future. Empire specializes in Diversified Green Energy projects. It is a full-service business. OTCQB-listed, Empire Diversified Energy is based in Fort Lauderdale, Florida.

The Company is currently initiating coal-reduction strategies involving increased use of sustainable biomass. Furthermore, Empire’s longer-term plans will be to diversify into zero-emission fuel science and the broad use of economically-viable hydro-electric, solar, and wind technologies. Empire provides strategic consulting and unique environmental solutions to address industry issues including the CCR remediation and renewable energy alternatives. The Company has identified a niche market opportunity in the fly ash remediation sector.

Empire plans to acquire certain assets. These include, but are not limited to, logistical equipment, coal mines, landfills, solar equipment, and biomass inventories. This is because it is working to implement a vertical integration strategy. It is now developing a hybrid alternative fuel pellet (HAFP). The intention of HAFP is to permit utilities and other enterprises that now burn solid and gaseous fuel sources to transition from these traditional sources to HAFP’s. Empire is also developing its own proprietary binding agent. This binding agent will allow HAFP’s to be used across a broader array of platforms.

Recently, Empire Diversified Energy announced that it received the first tranche of investment funds from a private equity group. The funds were used to pay off existing debt related to the Dickerson site in Cadiz, Ohio and to expand operations at the site. This funding retired the remaining debt on the site, which was acquired with the purchase of 100 percent of the membership rights of DTE Dickerson LLC. A Michigan LLC in April of 2017. This financing also provides much needed working capital to expand the reclamation project.

Empire Diversified Energy, Inc. (MPIR), closed Wednesday's trading session at $0.54, up 125.0938%, on 671 volume with 3 trades. The average volume for the last 3 months is 14 and the stock's 52-week low/high is $0.239899992/$2.00.

chart

Tapinator, Inc. (TAPM)

NetworkNewsWire, Tip Ranks, Zacks, Equity Clock, Penny Stock Tweets, Pennybuster, Insider Financial, YCharts, Investors Hangout, TopPennyStockMovers, Simply Wall St, Wallet Investor, Barchart, Stockopedia, Canadian Insider, Marketbeat, TheMicrocapNews, Street Register, Marketwired, and Crypto News Breaks reported previously on Tapinator, Inc. (TAPM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Tapinator, Inc. is a developer and publisher of mobile games and decentralized applications on the iOS, Google Play, Amazon and Ethereum platforms. The Company generates revenues through the sale of branded advertisements, paid downloadable games, as well as premium in-game content. Mr. Ilya Nikolayev is the Company’s Chief Executive Officer (CEO). Mr. Nikolayev is an accomplished technology executive. He formerly served as the CEO and Co-Founder of Familybuilder.

Tapinator is headquartered in New York, New York. An emerging mobile gaming leader, the Company has product development teams in the United States, Canada, Germany, Pakistan, Indonesia, and Russia. Formed in 2013, Tapinator lists on the OTC Markets’ OTCQB.

Tapinator's portfolio consists of more than 300 mobile gaming titles. These collectively have achieved greater than 450 million player downloads. This includes games such as ROCKY™, Video Poker Classic, Solitaire Dash and Dice Mage. The Company has shifted its focus from Rapid-Launch Games to the more lucrative Full-featured Games opportunity.

Tapinator has established a new subsidiary, Revolution Blockchain, LLC, to develop and publish distributed apps and games that take advantage of blockchain technology. Revolution Blockchain's initial product will leverage blockchain technology for payment (the purchase and sale of virtual assets) and the storage of these assets by way of non-fungible tokens that live on the blockchain.

Tapinator has released the Early Access version of BitPainting. This is a crypto-collectibles platform for the global art market. This past August, Tapinator announced a global distribution deal for its Solitaire Dash mobile game with Cheetah Mobile (CMCM). With this four-year initial agreement, CMCM becomes the exclusive international distributor for all mobile versions of the Solitaire Dash game. CMCM is a foremost mobile internet company. It aims to provide leading apps for mobile users around the world and connect users with personalized content powered by Artificial Intelligence (AI).

Recently, Tapinator announced financial results for the quarter and nine months ended September 30, 2018 and the filing of its quarterly report with the Securities and Exchange Commission (SEC). For the quarter ended September 30, 2018, Tapinator achieved Revenue of roughly $681,000, Bookings of $1,088,000, a Net Loss of roughly $608,000, and adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of roughly ($26,000). These represent year-over-year changes of -20 percent, 21 percent, 20 percent and -121 percent, respectively.

Mr. Andrew Merkatz, President of Tapinator, commented on the quarterly results, "Overall, our year-to-date results and outlook for the 2018 full year have come in below our earlier expectations. While we believe strongly in our core strategy of focusing on a limited number of Full-Featured Games and Apps that can achieve long-term leadership within their respective category, the growth in our Full-Featured business has been negatively impacted by new product launch delays, and the growth that we have achieved has been overshadowed by an accelerated decline from our legacy Rapid-Launch Games. On a positive note, however, the partnership that we announced at the beginning of Q3 with Cheetah Mobile for the distribution of Solitaire Dash is off to a strong start, and our near term product pipeline is robust.''

Tapinator, Inc. (TAPM), closed Wednesday's trading session at $0.0542, up 54.416%, on 27,679 volume with 10 trades. The average volume for the last 3 months is 87,111 and the stock's 52-week low/high is $0.015499999/$0.072499997.

chart

Spotlight Innovation, Inc. (STLT)

Penny Picks, Profitable Trader Authority, Damn Good Penny Picks, OTCtipReporter, Beacon Equity Research, SuperStockTips, InvestorSoup, PennyStockScholar, Journal Transcript, PennyStockLocks, StockRockandRoll, Elite Stock Alerts, Penny Stock Finder, Stock Preacher, Penny Stock Craze, Stock Commander, TopPennyStockMovers, Ceocast News, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Spotlight Innovation, Inc. advances technologies designed to address rare, emerging, and neglected diseases. The Company identifies and acquires rights to unique and proprietary platform technology candidates. Its emphasis is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and distinctive opportunities.

The Company’s subsidiaries include Celtic Biotech and Caretta Therapeutics, LLC. Spotlight Innovation is based in Urbandale, Iowa.

Spotlight Innovation’s mission is to considerably impact patient health through advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates’ is attained through its extensive relationships with numerous leading academic institutions and other sources. Spotlight provides value-added development capability and funding to expedite development progress.

The Company’s development pipeline includes product candidates for cancer, chronic pain, spinal muscular atrophy (SMA) and Zika virus infection. Spotlight works to acquire the rights, via acquisition, license, or otherwise, to innovative and proprietary Platform Technology Candidates. Additionally, it works to provide value-added development capability and funding to achieve fast IND approval to commence human clinicals for targeted Platform Technology Candidates.      

Spotlight Innovation has obtained from the Florida State University Research Foundation (FSURF) exclusive global rights to develop and commercialize certain compounds for the treatment of viral infections. This includes the Zika virus infection.

Spotlight Innovation subsidiary Caretta Therapeutics has its chronic pain relief product Venodol Roll-on. This product is a non-opioid, non-addictive topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation.

Spotlight Innovation has started Part 2 of a Phase 1 Cancer Trial. Its subsidiary, Celtic Biotech, started Part 2 of its Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. Contract Research Organization (CRO) ImmunoClin Ltd. is supervising the study conduct.

Spotlight Innovation has entered into a multi-year partnership agreement with Hip-Hope, Inc. (Des Moines, Iowa-based), an organization committed to using arts and culture to promote, advocate and support hope for at-risk youth wherever symptoms of hopelessness are widespread.

As part of this partnership, Spotlight Innovation is the title sponsor for Hip-Hope’s 2018 “#kidslivesmatter FUNraiser Challenge” to take place August 3, 2018, at the 7 Flags Event Center in Clive, Iowa. The annual event is a youth empowerment campaign. The design of it is to build kids’ character, physical health, as well as self-esteem.

Recently, Spotlight Innovation announced that Company research collaborator Professor Kevin Hodgetts was awarded a grant of $300,000 by the nonprofit organization Cure SMA for the project Pre-Clinical Development of LDN-5178 for the Treatment of SMA.

Spotlight Innovation holds an exclusive, worldwide development and commercialization license from Indiana University Innovation and Commercialization Office for LDN-5178 and a group of related compounds. This includes STL-182.

Spotlight Innovation, Inc. (STLT), closed Wednesday's trading session at $0.0338, up 135.5401%, on 2,444 volume with 3 trades. The average volume for the last 3 months is 1,254 and the stock's 52-week low/high is $0.002/$0.039.

chart

Tempus Applied Solutions Holdings, Inc. (TMPS)

MarketWatch and InvestorsHub reported on Tempus Applied Solutions Holdings, Inc. (TMPS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.  

Tempus Applied Solutions Holdings, Inc. provides design, engineering, systems integration, and flight operations solutions. These support critical aviation mission requirements for a variety of customers. The OTCQB-listed Company maintains a highly qualified and skilled in-house engineering team, which supports aircraft modifications, certification, maintenance,  and flight testing.

Tempus Applied Solutions,  LLC is the wholly-owned subsidiary of Tempus Applied Solutions Holdings; Inc.  Tempus Applied Solutions has its corporate office in Williamsburg, Virginia. The Company uses a secure facility with hangar and manufacturing space and secure communications at Brunswick Executive Airport. The facility has two parallel 8000’ x 200’ runways and a 4.5-million-square-foot ramp and taxiways - certified for B-747, A-340, and  and C-5 aircraft. 

Tempus has in-house DER (Designated Engineering Representatives) capabilities covering 41 categories of aircraft systems. Capabilities include Part 23 Aircraft and Part 25 Aircraft and also Repair Station DER. In addition, authorities encompass mechanical systems, electrical systems, and flight testing.

The Tempus Design & Engineering Center of Excellence has Designated Engineering Representative (DER) authority from the Federal Aviation Administration (FAA) and the European Aviation Safety Agency (EASA). This center’s specialties include major airframe modifications; interior completions projects; design and materials specifications; modeling and rendering utilizing 3D Max Vision; Supplemental Type Certificates (STC); and Layout of Passenger Accommodations (LOPA) Development.

Tempus flies airplanes - fixed wing and rotary, manned or unmanned. The Company engages in surveillance missions in Africa to flight training in Texas. Also, Tempus designs and modifies aircraft for special missions, certifies them, and provides turnkey lease and service solutions. 

Tempus operates Gulfstream, Bombardier, Pilatus, and Cessna aircraft. The majority of these aircraft have been specially modified by the Company for Department of Defense  (DoD)-related missions. This includes threat simulation, surveillance, communications relay, and diverse test and development programs.

The Tempus Applied Solutions subsidiary was awarded FAA  (Federal Aviation Administration)  approval, in the form of a Supplemental Type Certificate (STC), for Tempus' initial FANS/1-A and ADS-B compliance solution [(Tempus' "Solution AA")]. Tempus' solution received an "Approved Model List", or AML, STC. This means that it can be applied to any business and commercial aircraft.  FANS and ADS-B compliance will be mandated in most parts of the world by 2020.

Recently, Tempus Applied Solutions announced that it finalized the acquisition of six Lockheed L-1011s previously owned and operated by the Royal Air Force (RAF) of the United Kingdom. Four of these aircraft are specifically configured for air-to-air refueling (AAR) operations. The remaining two are configured for passenger and cargo operations only. The aircraft beforehand served the RAF and NATO.

Tempus Applied Solutions Holdings, Inc. (TMPS), closed Wednesday's trading session at $0.62, up 30.5263%, on 258,166 volume with 174 trades. The average volume for the last 3 months is 22,834 and the stock's 52-week low/high is $0.031099999/$0.694999992.

chart

Eco Science Solutions, Inc. (ESSI)

Wall Street Mover, ThePUMPTracker, DSR News, Real Pennies, Promotion Stock Secrets, TopPennyStockMovers, Wallstreetlivechat, and Pumps and Dumps reported earlier on Eco Science Solutions, Inc. (ESSI), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Eco Science Solutions, Inc. is an eco-technology Company with its corporate headquarters in Makawao, Hawaii. It provides solutions to the multi-billion-dollar health, wellness, and alternative medicine industry. Eco Science Solutions develops technical solutions - from enterprise software solutions, to consumer applications (apps) for daily use. These solutions energize enthusiasts in their pursuit and enjoyment of building eco-friendly businesses and living healthy lifestyles. Eco Science Solutions’ shares trade on the OTC Markets Group’s OTCQB.

Eco Science Solutions’ key services cover localized communications between consumers and business operators, social networking with like-minded enthusiasts, rich educational content, e-commerce, and fast delivery of products. These all cater to the health-and-wellness lifestyle.

The Company’s brands include Herbo, Fitrix, and pHion Balance. The Herbo app assists consumers in finding products and services that support the intake of alternative medicines for a more naturopathic lifestyle. Herbo has a database of greater than 14,000 alternative medicine locations and delivery services, doctors who provide evaluations, and local shops that sell relevant product.

The Fitrix app is a strong and flexible companion. Fitrix assists users’ in keeping track of their day-to-day fitness routines, dietary habits, and alternative medicine intake. Fitrix users can measure and track anything and everything concerning their health and wellness.

The Company’s pHion Balance underwent development to create nutritional supplements, which support and promote a healthy lifestyle. pHion Balance is centered on developing nutritional supplements that take the guesswork out of supplementing the body in the healthiest way.

Eco Science Solutions will continue to make investments in e-commerce and mobile applications that facilitate B2C (Business-to-Consumer) e-commerce opportunities.

Eco Science Solutions' main projects have focused on continued consumer and enterprise technology investment; continued product formulation and inventory build for distribution; and strategic acquisitions, which provide an accelerated time-frame to obtain market share.

In May of 2017, the Company announced that it signed a Sponsorship, Content Development, and Licensing agreement with Roaring Lion Tours, Inc. Roaring Lion Tours develops inspirational and educational content that further promotes what it believes are the benefits of medical marijuana.  This agreement is to develop unique educational content that brings awareness and education to the alternative medicine category.

Eco Science Solutions, Inc. (ESSI), closed Wednesday's trading session at $0.015, up 50.00%, on 4,030 volume with 4 trades. The stock's 52-week low/high is $0.201000005/$4.80000019.

chart

Ecosphere Technologies, Inc. (ESPH)

TheMicrocapNews, PennyStocks24, Buzz Stocks, Penny Pick Finders, PennyStockProphet, SmallCapVoice, Wall Street Resources, Planet Penny Stocks, SecretStockPromo, and StockOnion reported earlier on Ecosphere Technologies, Inc. (ESPH), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ecosphere Technologies, Inc. is a development and Intellectual Property (IP) licensing company. It develops environmental solutions for global water, energy, industrial, and agricultural markets. The Company helps industry increase production, lessen costs, and protect the environment through a portfolio of inventive, patented technologies and exclusive and nonexclusive licensing opportunities across a wide spectrum of industries and applications globally. Ecosphere Technologies is based in Stuart, Florida.

Ecosphere has a wide-ranging portfolio of patented clean technologies. These can be purchased and licensed for use in large-scale and sustainable applications across industries, nations, and ecosystems. The Company’s technologies include the Ecos PowerCube®, the Ecos GrowCube™, and Ozonix®.

The Ecosphere technologies and products are available via many brands and subsidiaries. These include Sea of Green Systems, Ecosphere Development Company, and Fidelity National Environmental Solutions. The Company’s goal is to help clean energy producers’ gain more control over their water resources, quality, and completion costs through providing effective mobile water recycling solutions.

The Ecosphere Ozonix® Technology provides a chemical-free alternative to high-volume water recycling for a varied range of applications. These range from the oil & natural gas industry and mining to agriculture and municipal wastewater treatment. The oil and natural gas industry is successfully using Ecosphere Technologies’ patented Ozonix® technology to treat and recycle the water used in oil and natural gas well drilling and completion programs.

The Ecos PowerCube® is the world’s largest, mobile, solar-powered generator. It runs on high power photovoltaic panels. These panels extend from its container combined with an easy to set up wind turbine. Energy is stored in onboard batteries.  

The Ecos GrowCube® is a state-of-the-art, turn-key, fully-automated "greenhouse". It uses hydroponic growing techniques to maximize the amount of crop production possible in a given footprint. The Ecos GrowCube® incorporates Ecosphere’s patented Ozonix® water treatment technology. In addition, Ecosphere has its Ozonix Sentinel. This is the world's first line of water treatment vessels for cleaning up endangered rivers and lakes.

Sea of Green Systems (SOGS), a subsidiary of Ecosphere Technologies, announced in January 2017 the launch of its SOGS-650X, Full Spectrum LED Growing Light. This light was developed to provide growers with an engineered solution to maximize vegetative growth and flower production for the indoor agriculture and legal marijuana industries.

The SOGS-650X can produce greenhouse-like conditions through providing an average 25 DLI (Daily Light Integral) during the Vegetative and Flowering Cycles, with about 450-650 uMols and 700-900 uMols at the plant canopy during their respective growth cycles. Sea of Green Systems (SOGS) sells high-tech growing equipment, lighting solutions, and nutrients to the Precision Agriculture industry.

Recently, Sea of Green Systems announced that its sublicensee in the agricultural industry, Gulf Coast Organics (GCO), signed an agreement with Wedgworth's, Inc., to be the exclusive distributor in Florida for its Amp Agronomy™ plant nutritional line. Wedgworth's is recognized as Florida's largest custom fertilizer dealer since 1932. Wedgworth's provides custom blended agricultural plant nutrient products across Florida to help farms grow and prosper. CAVISONIX®, developed by SOGS and Ecosphere Technologies, utilizes ultrasonic cavitation to treat fertilizers for increased plant availability.

Ecosphere Technologies, Inc. (ESPH), closed Wednesday's trading session at $0.0025, up 78.5714%, on 57,500 volume with 7 trades. The average volume for the last 3 months is 171,368 and the stock's 52-week low/high is $0.0005/$0.018899999.

chart

American Power Group Corp. (APGI)

Marketbeat.com, Stock News Now, and SmallCapVoice reported on American Power Group Corp. (APGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, as well as off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts and lists on the OTC Markets Group’s OTCQB.

The Company’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run simultaneously on diesel and different kinds of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time.  It is a ground-breaking non-invasive energy enhancement system.

American Power Group (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs) that can sell as heating fluids, emulsifiers, or be further processed by refiners. Via the Company’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.  

Regarding American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad collection of engine models and end-market applications demands no engine modifications.

Recently, American Power Group announced that it will extend the filing of its June 30, 2017 Quarterly Form 10Q through SEC Form 12b-25.  The Company announced on June 6, 2017, a corporate wide realignment of its strategic direction, reallocation of resources, and reduction in workforce in response to considerable operating losses because of the effect that ongoing low oil prices were having on its dual fuel and flare capture businesses. The realignment resulted in a decrease in annual operating costs of greater than $2 million on a going forward basis.

American Power Group Corp. (APGI), closed Wednesday's trading session at $0.01, off by 16.6667%, on 42,205 volume with 5 trades. The average volume for the last 3 months is 13,833 and the stock's 52-week low/high is $0.002899999/$0.137500002.

chart

The QualityStocks Company Corner

Quest Patent Research Corp. (OTCQB: QPRC)

The QualityStocks Daily Newsletter would like to spotlight Quest Patent Research Corp. (OTCQB: QPRC).

Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.

Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.

Objectives

Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:

  • IP Valuation
  • Structured Licensing Programs
  • Patent Prosecution
  • Partial or Full Liquidity
  • Portfolio Evaluation
  • Portfolio Maintenance
  • Legal Advisory
  • Attorney/Investor Referral
  • Patent Acquisition/Liquidation

At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.

Management

Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.

Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.

Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.

Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.

Quest Patent Research Corp. (OTCQB: QPRC), closed Wednesday's trading session at $0.0127, off by 9.2857%, on 60,400 volume with 5 trades. The average volume for the last 3 months is 281,167 and the stock's 52-week low/high is $0.0013/$0.039999999.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. The winds of change regarding marijuana laws around the country have evoked the lyrics of Bob Dylan when he wrote “The Times They Are a-Changin’” nearly 60 years ago. In fact, a court of law in Maryland quoted those very lyrics during its landmark ruling in a marijuana case in which the police was told they didn’t have “probable cause” to search the appellant just because the officers could smell pot.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Wednesday's trading session at $3.42655, up 3.4586%, on 18,608 volume with 51 trades. The average volume for the last 3 months is 41,538 and the stock's 52-week low/high is $2.51999998/$6.00810003.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) recently announced that it has applied for a listing of its common shares on the Nasdaq. The listing will require numerous regulatory moves on the part of the company, including registration of the common shares and a confirmation by the Nasdaq that TGOD has met all applicable listing requirements.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Wednesday's trading session at $2.48, up 3.7657%, on 374,776 volume with 480 trades. The average volume for the last 3 months is 608,985 and the stock's 52-week low/high is $1.60699999/$7.89379978.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that its Chairman and Chief Executive Officer, Rodney Varner, is scheduled to present at the 4th Annual Disruptive Growth Conference hosted by ReedSmith in New York City on September 4, 2019. Also today, NetworkNewsWire released a report on the company detailing how GNPX is poised to profit as biotech and biopharma industry leaders are posting record financials and hitting milestone markers in their research and growth, good indicators of a strong market with potential for robust returns on investment.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Wednesday's trading session at $0.9524, up 4.3269%, on 28,428 volume with 42 trades. The average volume for the last 3 months is 55,817 and the stock's 52-week low/high is $0.640999972/$2.75999999.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTC:LXRP) (CNSX:LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce the online commercial launch of ChrgD+, the industry's most advanced water-soluble multi-spectrum hemp oil in a powdered format and empowered with DehydraTECHTM for fast, effective delivery. For sale now to US consumers at chrgd.life

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.7776, up 0.987013%, on 67,750 volume with 68 trades. The average volume for the last 3 months is 89,859 and the stock's 52-week low/high is $0.600000023/$2.24.

Recent News

chart

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)

The QualityStocks Daily Newsletter would like to spotlight Nabis Holdings (OTC: NABIF).

Nabis Holdings Inc. (CSE:NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis™” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today issued a letter to shareholders detailing its recent acquisitive activity that is laying the framework for building a leading cannabis asset manager.

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."

Strategy

While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.

Criteria for investment targets are as follows:

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSOs (Multi-state Operators) with strong brand traction
  • Pharma grade cultivation, extraction, dispensaries and other addressable operations

Current Endeavors

Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.

Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.

Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.

Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.

Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.

Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.

Proven Management Team

CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.

President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.

Nabis Holdings (OTC: NABIF), closed Wednesday's trading session at $0.15, up 1.5572%, on 19,498 volume with 8 trades. The average volume for the last 3 months is 52,657 and the stock's 52-week low/high is $0.119249999/$0.791499972.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

A technology holding company, VPR Brands LP (OTC: VPRB) is focused on growing its brand presence in the cannabis industry by pioneering innovative products that garner customer loyalty. The company has a vested interest in supporting the cannabis industry and recently took the initiative to sponsor a comprehensive examination of presidential candidates’ stances on cannabis policies. This study is the first of its kind and signifies VPR Brands’ leadership in the ever-evolving cannabis industry.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Wednesday's trading session at $0.0735, up 5.00%, on 2,238 volume with 3 trades. The average volume for the last 3 months is 114,435 and the stock's 52-week low/high is $0.033799998/$0.119999997.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions (OTCQB: SGSI), a leading single-source provider of telecommunications engineering and infrastructure services, engages in engineering, upgrading, installing and maintaining next-generation telecommunications networks. To view the full article, visit: http://nnw.fm/fC00S.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Wednesday's trading session at $0.06, up 4.6025%, on 17,870 volume with 4 trades. The average volume for the last 3 months is 66,642 and the stock's 52-week low/high is $0.032000001/$2.5999999.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) today announced an interview with the Company’s CEO Greg Lambrecht will air on The RedChip Money Report television program. The interview will air Sunday, August 25, on Bloomberg International, available in 149 million homes across Europe, the Middle East, and Africa. Check local listings for times in your area.  To view the interview segment, please visit:  https://youtu.be/gkXbc4DUgxQ. Also today, NetworkNewsWire released a report on the company detailing how SING recently acquired solar energy business Direct Solar, significantly broadening the company. To view the full article, visit: http://nnw.fm/uHk11

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Wednesday's trading session at $0.0135, up 2.2727%, on 2,437,960 volume with 95 trades. The average volume for the last 3 months is 3,430,493 and the stock's 52-week low/high is $0.009999999/$0.041000001.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, recently announced an initial investment in Hempistry Inc. To view the full article, visit: http://nnw.fm/8NauO.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Wednesday's trading session at $0.0132, up 3.125%, on 1,838,635 volume with 69 trades. The average volume for the last 3 months is 6,146,623 and the stock's 52-week low/high is $0.00975/$0.197500005.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Geyser Brands Inc. (TSX.V: GYSR), a global science-led consumer health care company, builds and markets some of the world’s leading cannabis products and brands. As a licensed producer in Canada under the Cannabis Act, Geyser operates a production and processing facility in Port Coquitlam, British Columbia, developing unique products for healthy lifestyle brands (http://nnw.fm/HnpD4). Also today, the company was highlighted in a publication from CFN Media, examining how GYSR has been awarded conditional approval by the TSX, and expects the transaction to be completed by the end of August, pending final approval from the Exchange through a simple majority of the company's shareholders.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed Wednesday's trading session at $0.51, even for the day. The stock's 52-week low/high is $0.479999989/$0.850000023.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech Inc. (OTCQB: ETST) outlined a five-year plan in its July 10-K annual report filed with the SEC. The report details a strategy of creating ETST’s proprietary line of CBD hemp extracts through a gentle and natural process that utilizes a super-critical extraction process using CO2 compression, isolation and micron filtration (http://nnw.fm/sXqz2).

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Wednesday's trading session at $0.7399, off by 5.141%, on 55,774 volume with 17 trades. The average volume for the last 3 months is 59,245 and the stock's 52-week low/high is $0.300999999/$2.45000004.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed Wednesday's trading session at $0.338, off by 1.1811%, on 145,542 volume with 79 trades. The average volume for the last 3 months is 262,418 and the stock's 52-week low/high is $0.189099997/$0.850000023.

Recent News

chart

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.

Products

The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.

Cannabis

Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.

Management

Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed Wednesday's trading session at $0.022, even for the day. The tock's 52-week low/high is $0.009899999/$0.028999999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.